Inventor · disambiguated record
Ulhas R. Dhuppad
Also filed as: DHUPPAD ULHAS · DHUPPAD ULHAS R · DHUPPAD ULHAS RAMESHCHANDRA
23 granted patents·22 pending applications·61 citations·filing 2007–2025
93Inventor score
Files withGLENMARK SPECIALTY SA20GLENMARK PHARMACEUTICALS LTD12ALKEM LABORATORIES LTD4GLENMARK PHARMACEUTICALS SA4DHUPPAD ULHAS3
Top patents by PatentIndex Score
45 records- 0192US9370483B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jun 21, 2016·8 cites·21 claims
- 0291US12303635B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2023·Granted May 20, 2025·1 cites·10 claims
- 0391US9750754B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2016·Granted Sep 5, 2017·6 cites·51 claims
- 0490US9987260B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2017·Granted Jun 5, 2018·5 cites·39 claims
- 0590US9078923B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 14, 2015·24 cites·21 claims
- 0689US9757365B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2016·Granted Sep 12, 2017·6 cites·35 claims
- 0779US9937189B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2016·Granted Apr 10, 2018·1 cites·36 claims
- 0870US10632109B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted Apr 28, 2020·0 cites·58 claims
- 0970US2025064735A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1068US10765686B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Sep 8, 2020·0 cites·14 claims
- 1168US10561672B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Feb 18, 2020·0 cites·22 claims
- 1268US10517880B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Dec 31, 2019·0 cites·33 claims
- 1368US10376526B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Aug 13, 2019·0 cites·32 claims
- 1468US8404727B2Pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitorDHUPPAD ULHAS·Filed 2010·Granted Mar 26, 2013·5 cites·9 claims
- 1567US11679210B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2018·Granted Jun 20, 2023·1 cites·16 claims
- 1667US10632108B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2018·Granted Apr 28, 2020·0 cites·20 claims
- 1766US12502489B1Metered dose inhaler for ipratropium bromide solutionGLENMARK PHARMACEUTICALS LTD·Filed 2024·Granted Dec 23, 2025·0 cites·22 claims
- 1866US2025161328A1Nasal spray compositionGLENMARK SPECIALTY SA·Filed 2024·Application pending·0 cites
- 1964US2025242115A1Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2025·Application pending·0 cites
- 2062US2011105448A1Stable Topical Formulation Comprising VoriconazoleGLENMARK PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2161US2020197370A1NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITORGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 2259US2021196631A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2355US10653683B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted May 19, 2020·0 cites·71 claims
- 2455US10357622B2Dry powder inhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 23, 2019·1 cites·17 claims
- 2555US8673356B2Stable fixed dose topical formulationDHUPPAD ULHAS RAMESHCHANDRA·Filed 2009·Granted Mar 18, 2014·1 cites·9 claims
- 2654US2023240985A1Stable pharmaceutical composition of topiramateALKEM LABORATORIES LTD·Filed 2023·Application pending·0 cites
- 2752US2020163955A1Sterile compositions of indacaterol suitable for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Application pending·0 cites
- 2851US2019275269A1Dry Powder InhalerGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2951US2023210830A1Stable pharmaceutical composition of nimodipineALKEM LABORATORIES LTD·Filed 2022·Application pending·0 cites
- 3050US10603277B2Nanoparticulate formulation comprising a TRPA1 antagonistGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Mar 31, 2020·0 cites·5 claims
- 3150US2008249120A1Pharmaceutical compositionsGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3248US10555903B2Nebulizable compositions of tiotropium and formoterolGLENMARK SPECIALTY SA·Filed 2017·Granted Feb 11, 2020·0 cites·30 claims
- 3346US2020215051A1Nebulization composition comprising tiotropium and indacaterolGLENMARK SPECIALTY SA·Filed 2020·Application pending·0 cites
- 3446US2011160213A1Pharmaceutical compositions for the treatment of inflammatory and allergic disordersGLENMARK PHARMACEUTICALS SA·Filed 2008·Application pending·0 cites
- 3545USD1063062SNasal spray deviceALKEM LABORATORIES LTD·Filed 2022·Granted Feb 18, 2025·2 cites·1 claims
- 3643US2023218630A1Combination of alcaftadine and a corticosteroidALKEM LABORATORIES LTD·Filed 2021·Application pending·0 cites
- 3742US2020345671A1Topical pharmaceutical composition of adapalene and minocyclineGLENMARK PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 3840US2015297523A1Pharmaceutical composition comprising bendamustineDHUPPAD ULHAS·Filed 2014·Application pending·0 cites
- 3939US2017135991A1NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITORGLENMARK PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 4038US2018133151A1Nebulized tiotropiumGLENMARK SPECIALTY SA·Filed 2017·Application pending·0 cites
- 4138US2010323998A1Topical composition containing the combination of mupirocin and beclomethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 4236US10709663B2Mupirocin cream in pump deviceGLENMARK PHARMACEUTICALS INC USA·Filed 2019·Granted Jul 14, 2020·0 cites·6 claims
- 4335US2013028977A1Pharmaceutical powder composition for inhalationGLENMARK PHARMACEUTICALS LTD·Filed 2011·Application pending·0 cites
- 4435US2016310410A1Pharmaceutical compositions comprising arformoterol and glycopyrroniumGLENMARK SPECIALTY SA·Filed 2016·Application pending·0 cites
- 4530US2013203778A1Pharmaceutical composition comprising a pyrimidineone derivativeDHUPPAD ULHAS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulhas R. Dhuppad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →